WNBA Aligns With NBA and NFL In Relaxing Marijuana Rules

Marijana is no longer on the WNBA’s list of banned substances under the new Collective Bargaining Agreement (CBA).

The new CBA reflects a shift in treating marijuana differently from other controlled substances, prioritizing player health and impairment concerns, as reported by Marijuana Moment.

This change has effectively eliminated routine marijuana testing. Players can still be tested if they are in the league’s drug program, appear impaired during team or league activities, or have a marijuana-related substance-use problem. Moreover, failing to follow treatment requirements can lead to penalties, including daily fines and increasing suspensions for repeated violations.

The WNBA’s move means players may now invest in marijuana companies if they hold a passive ownership stake of less than 50% and the company complies with all applicable laws and regulations.

Furthermore, they may own and actively operate CBD companies. That includes holding majority ownership in a CBD company and publicly promoting and endorsing CBD products.

A number of sports leagues have already moved in this direction.

The National Basketball Association removed marijuana from its banned substances list in 2023. The National Collegiate Athletic Association did the same in 2024.

The National Football League (NFL) reformed its marijuana policies the same year by reducing fines for positive tests while increasing the allowable THC threshold for players.

In the meantime, the WNBA has expanded its banned substances list to include psychedelics like DMT, ibogaine, psilocybin, and psilocin, as well as synthetic cannabinoids such as Delta-8 THC and similar compounds.